masoprocol has been researched along with Carcinosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honn, KV; Tang, DG | 1 |
| Chen, YQ; Guan, KL; Honn, KV; Li, L; Porter, AT; Rice, RL; Tang, DG; Taylor, JD | 1 |
2 other study(ies) available for masoprocol and Carcinosarcoma
| Article | Year |
|---|---|
Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival.
Topics: Animals; Apoptosis; Arachidonate 12-Lipoxygenase; Carcinosarcoma; Cell Survival; Glutathione; Lipid Peroxides; Lipoxygenase Inhibitors; Masoprocol; Mice; Monocytes; Rats; Reactive Oxygen Species; Rhodamines; Rotenone; Tumor Cells, Cultured | 1997 |
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetophenones; Animals; Apoptosis; Arachidonic Acid; Calcimycin; Carcinosarcoma; Cell Line; Cell Survival; Cytokines; DNA Fragmentation; Fatty Acids, Nonesterified; Growth Substances; Hydroxyeicosatetraenoic Acids; Kinetics; Masoprocol; Rats; Tumor Cells, Cultured | 1997 |